Report Slams "Bloomberg" Over Article on Pluristem Girl's Death

Report slams "Bloomberg" over article on Pluristem girl's death

Filed under: drug treatment news articles

Last Wednesday, "Bloomberg" alleged that Pluristem concealed the death of a 7-year old girl who had received the company's placental stem cells under Israel's compassionate use program for experimental drugs, and that the company's announcements were …
Read more on Globes

 

In Second-Line Treatment of Advanced NSCLC, Adding Carboplatin to

Filed under: drug treatment news articles

“On the basis of this result, single-drug therapy with last-generation agents, such as pemetrexed or docetaxel, should remain the standard of care in second-line chemotherapy treatment of NSCLC,” they wrote. The US Food and Drug Administration (FDA …
Read more on Cancer Network

 

Processing Aegerion Pharmaceuticals' Recent Rally

Filed under: drug treatment news articles

After its recent rally, shares of Aegerion have been brought to a new market cap just under $ 500 million, which prices in an approval for lomitapide and a valuation of the drug that implies a relatively low market penetration into the $ 30 billion …
Read more on SmallCap Network

 

Why Questcor Fears Were Overblown

Filed under: drug treatment news articles

It all started with the Food and Drug Administration granting orphan drug designation on Oct. 31 to Cerium Pharmaceuticals for Synacthen Depot in the treatment of infantile spasms. Online financial news source Benzinga initially reported the news …
Read more on Motley Fool